| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/31/2006 | US20060194281 decrease inhibit or prevent viral propagation or screening of compounds impaction on the expression of shorter form core+1 protein; antiviral agents |
| 08/31/2006 | US20060194280 Methods for refolding of recombinant antibodies |
| 08/31/2006 | US20060194276 Specificity grafting of a murine antibody onto a human framework |
| 08/31/2006 | US20060194267 Secifically a Borrelia, Babesia, or Ehrlichia; enzyme-linked immunoassay test, blot analysis, or Multi-Peptide ELISA Blot analysis of antibody levels; Lyme Disease |
| 08/31/2006 | US20060194265 Novel therapeutic targets in cancer |
| 08/31/2006 | US20060194247 Complex of antigen, antibody or ligand, receptor; therapy or prevent human disease |
| 08/31/2006 | US20060194235 HLJ1 gene expression |
| 08/31/2006 | US20060194219 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/31/2006 | US20060194211 Methods for prognosis and treatment of solid tumors |
| 08/31/2006 | US20060194204 Gene expressed in prostate cancer, methods and use thereof |
| 08/31/2006 | US20060194197 Biosensors utilizing dendrimer-immobilized ligands and their use thereof |
| 08/31/2006 | US20060193874 Vaccines for proliferative ileitis and methods of making and using the same |
| 08/31/2006 | US20060193873 Functionallly reconstituted viral membranes containing adjuvant |
| 08/31/2006 | US20060193870 Compositions and methods for the therapy and diagnosis of colon cancer |
| 08/31/2006 | US20060193867 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith |
| 08/31/2006 | US20060193866 H pylori antigens |
| 08/31/2006 | US20060193865 Camptothecin-binding moiety conjugates |
| 08/31/2006 | US20060193864 Conversion of apoptotic proteins |
| 08/31/2006 | US20060193863 Compositions and methods for diagnosing and treating prostate cancer |
| 08/31/2006 | US20060193861 Tumor necrosis factor receptors 6 alpha & 6 beta |
| 08/31/2006 | US20060193860 Treatment of schizophrenia |
| 08/31/2006 | US20060193859 Methods of Treatment Using Antibodies to Neutrokine-alpha |
| 08/31/2006 | US20060193858 Full-lenth, isolated polypeptide comprising a polypeptide sequence of human SRC-like adaptor protein |
| 08/31/2006 | US20060193856 Aglycosyl anti-CD154 (CD40 ligand) antibodies and uses thereof |
| 08/31/2006 | US20060193854 a cancer which expresses epidermal growth factor receptor; blocking ligand activation of a receptor; binding of monoclonal antibody 2C4 to ErbB2; chemotherapeutic agents are 5-fluorouracil leucovorin, levamisole |
| 08/31/2006 | US20060193852 immunotherapy, preferably against B-cell malignancies such as non-Hodgkin lymphoma; single-chain multifunctional polypeptides comprising at least two binding sites specific for the CD19 and CD3 antigen; domains are arranged in the order VLCD19-VHCD19-VHCD3-VLCD3; vector; cell |
| 08/31/2006 | US20060193851 Human anti-factor IX/IXa antibodies |
| 08/31/2006 | US20060193849 Biological materials and uses thereof |
| 08/31/2006 | US20060193848 Mammalian tumor susceptibility genes and their uses |
| 08/31/2006 | US20060193847 Peptides for inhibiting retroviruses |
| 08/31/2006 | US20060193828 Expression enhancer for HM1.24 antigen |
| 08/31/2006 | US20060193771 Anti-cd30 stalk and anti-cd30 antibodies suitable for use in immunotoxins |
| 08/31/2006 | CA2601932A1 Peptides for detection of antibody to porcine reproductive respiratory syndrome virus |
| 08/31/2006 | CA2599439A1 Ykl-40 monoclonal antibody |
| 08/31/2006 | CA2598823A1 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 08/31/2006 | CA2598475A1 Protein and its use in diagnosing alzheimer's disease |
| 08/31/2006 | CA2598004A1 Adamts-7 as a biomarker for cancers of epithelial origin |
| 08/30/2006 | EP1696033A2 Pseudomonas exotoxin A-like chimeric immunogens |
| 08/30/2006 | EP1696031A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 08/30/2006 | EP1696030A1 TIE ligand homologues |
| 08/30/2006 | EP1696029A1 TIE ligand homologues |
| 08/30/2006 | EP1696028A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/30/2006 | EP1696027A1 Hla-dr-binding antigen peptide derived from wt1 |
| 08/30/2006 | EP1695986A2 Anti-erb B2 antibodies |
| 08/30/2006 | EP1695985A2 Humanized antibodies and methods for forming humanized antibodies |
| 08/30/2006 | EP1695984A1 Reference material for assaying d-dimer |
| 08/30/2006 | EP1695978A1 Nucleic acid ligands |
| 08/30/2006 | EP1695702A2 Treatment of metastatic disease |
| 08/30/2006 | EP1695093A1 Compositions and methods for the treatment and diagnosis of neoplastic and infectious diseases |
| 08/30/2006 | EP1695078A2 Metadherin polypeptides, encoding nucleic acids and methods of use |
| 08/30/2006 | EP1695061A2 Method for treating neurological disorders |
| 08/30/2006 | EP1694850A2 Plasmid system for multigene expression |
| 08/30/2006 | EP1694845A1 Anticarcinoma antibidies and uses thereof |
| 08/30/2006 | EP1694830A2 Novel atypical pneumonia-causing virus |
| 08/30/2006 | EP1694709A1 Recombinant anti-cd64-immunotoxins |
| 08/30/2006 | EP1694708A2 Anti-idiotype antibodies of the human monoclonal antibody sc-1, and their production and use |
| 08/30/2006 | EP1694707A1 Human anti-idiotypic antibody fragments that mimic her-2/neu |
| 08/30/2006 | EP1694706A2 Modified anti-cd52 antibody |
| 08/30/2006 | EP1694705A2 Interleukin-10 antibodies |
| 08/30/2006 | EP1694704A2 Peptide hormones zalpha48 and zsig97 |
| 08/30/2006 | EP1694701A2 Pp2a/bgamma subunits, modulators thereof, and their uses in the treatment of mental disorders |
| 08/30/2006 | EP1694700A1 Neutralizable epitope of hgf and neutralizing antibody binding to the same |
| 08/30/2006 | EP1694697A2 Surface-located campylobacter jejuni polypeptides |
| 08/30/2006 | EP1694666A2 Novel spliced 5-ht1a receptors and methods, kits, and uses relating thereto |
| 08/30/2006 | EP1694360A2 Use of antagonist anti-cd40 antibodies for treatment of autoimmune and inflammatory diseases and organ transplant rejection |
| 08/30/2006 | EP1694359A2 Compositions for reducing bacterial carriage and cns invasion and methods of using same |
| 08/30/2006 | EP1694349A2 Integrin alpha ii beta3 specific antibodies and peptides |
| 08/30/2006 | EP1694301A2 Methods and compositions for the production of monoclonal antibodies |
| 08/30/2006 | EP1485128A4 Nanostructures containing antibody assembly units |
| 08/30/2006 | EP1479773B1 Mite galectin |
| 08/30/2006 | EP1334188B1 Cd19-specific redirected immune cells |
| 08/30/2006 | EP1297011B1 Diagnostic uses of the t-cell protein tzon7, and of the peptides and antibodies derived therefrom |
| 08/30/2006 | EP1266008B1 Acute neuronal induced calcium binding protein type 1 ligand |
| 08/30/2006 | EP1133558B1 Compositions and methods for increasing bone mineralization |
| 08/30/2006 | EP1098971B1 Myotilin, an actin-organizing protein |
| 08/30/2006 | EP1037900A4 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies |
| 08/30/2006 | EP0972036B1 Prion propagation inhibition by dominant-negative prion protein mutants |
| 08/30/2006 | EP0934338B1 Cellular internalization of pigr stalk and associated ligands |
| 08/30/2006 | EP0909316B1 Glial cell line-derived neurotrophic factor receptor |
| 08/30/2006 | EP0728200B1 Haemophilus transferrin receptor genes |
| 08/30/2006 | EP0529033B1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof |
| 08/30/2006 | CN1826357A Cd55-interaction partners and the uses thereof |
| 08/30/2006 | CN1826356A Binding molecules against sars-coronavirus and uses thereof |
| 08/30/2006 | CN1826355A Monoclonal antibody against influenza B virus and immunoassay instrument using the antibody |
| 08/30/2006 | CN1826138A Rg1 antibodies and uses thereof |
| 08/30/2006 | CN1826137A Inducible ligand for alpha1beta1 integrin and uses |
| 08/30/2006 | CN1826130A Use of a PAK inhibitor for the treatment of a joint disease |
| 08/30/2006 | CN1824789A Preparation of testis specific protein 50 monoclonal antibody and polyclonal antibody and use |
| 08/30/2006 | CN1824777A Human g-protein coupled receptor |
| 08/30/2006 | CN1824679A Method of extracting pig immunoglobulin IgG in pig blood |
| 08/30/2006 | CN1824678A Preparation and use of testes specificity protein 50 human source antibody |
| 08/30/2006 | CN1824675A Neisserial antigens |
| 08/30/2006 | CN1272345C Silensed anti-CD 28 antibodies and use thereof |
| 08/29/2006 | US7098690 Programmable I/O element circuit for high speed logic devices |
| 08/29/2006 | US7098322 Tumor necrosis factor and proteins with amino acid sequences to modulate signal passageways |
| 08/29/2006 | US7098316 Isolated nucleic acid, coding regions of genes of proteins, vectors, host cells and genetic engineering for producing proteins and diagnosis of diseaes |
| 08/29/2006 | US7098312 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/29/2006 | US7098305 Sustained release of microcrystalline peptide suspensions |
| 08/29/2006 | US7098303 Immunogenic polypeptide; vaccine for therapy of HCV infection and assays for the diagnosis of HCV |
| 08/29/2006 | US7098184 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |